PEP/NEWS — Peptide intel. Daily.

BPC-157 AND TB-500 ARE THE TWO MOST CO-RESEARCHED PEPTIDES IN THE RECOVERY LITERATUREEPITALON TETRAPEPTIDE WAS FIRST ISOLATED BY VLADIMIR KHAVINSON IN THE 1980S FROM BOVINE PINEAL TISSUESEMAGLUTIDE PHASE 3 TRIALS SHOWED AVERAGE BODY WEIGHT REDUCTION OF ~15% OVER 68 WEEKSRETATRUTIDE IS THE ONLY GLP-1/GIP/GLUCAGON TRIPLE AGONIST CURRENTLY IN ACTIVE PHASE 3 TRIALSGHK-CU COPPER PEPTIDE PLASMA LEVELS DECLINE FROM ~200NG/ML AT AGE 20 TO UNDER 80NG/ML BY AGE 60TIME-RESTRICTED FEEDING IN A NEW NATURE AGING MOUSE STUDY EXTENDED HEALTHSPAN IN BOTH SEXESTHYMOSIN ALPHA-1 IS APPROVED AS AN IMMUNE MODULATOR IN OVER 35 COUNTRIES OUTSIDE THE USPHYSICAL ACTIVITY LINKED TO SLOWER EPIGENETIC AGING ACROSS MULTIPLE CLOCK MEASURES IN NEW SYSTEMATIC REVIEW BPC-157 AND TB-500 ARE THE TWO MOST CO-RESEARCHED PEPTIDES IN THE RECOVERY LITERATUREEPITALON TETRAPEPTIDE WAS FIRST ISOLATED BY VLADIMIR KHAVINSON IN THE 1980S FROM BOVINE PINEAL TISSUESEMAGLUTIDE PHASE 3 TRIALS SHOWED AVERAGE BODY WEIGHT REDUCTION OF ~15% OVER 68 WEEKSRETATRUTIDE IS THE ONLY GLP-1/GIP/GLUCAGON TRIPLE AGONIST CURRENTLY IN ACTIVE PHASE 3 TRIALSGHK-CU COPPER PEPTIDE PLASMA LEVELS DECLINE FROM ~200NG/ML AT AGE 20 TO UNDER 80NG/ML BY AGE 60TIME-RESTRICTED FEEDING IN A NEW NATURE AGING MOUSE STUDY EXTENDED HEALTHSPAN IN BOTH SEXESTHYMOSIN ALPHA-1 IS APPROVED AS AN IMMUNE MODULATOR IN OVER 35 COUNTRIES OUTSIDE THE USPHYSICAL ACTIVITY LINKED TO SLOWER EPIGENETIC AGING ACROSS MULTIPLE CLOCK MEASURES IN NEW SYSTEMATIC REVIEW

Last updated June 11, 2026 — I read this morning's peptide research and picked the items that mattered. Fresh brief tomorrow.

◤ Top story · Research Vials
PEPTIDES AND CANCER: RESEARCH VIALS PUBLISHES THREE-PART DEEP DIVE ON TUMOR BIOLOGY, GH SECRETAGOGUES, AND RISK STRATEGY...

*Three-part series maps tumor pathways, metastasis brakes, and GH secretagogue risk in one reference.*

Research Vials

Featured Briefs

◤ From the network · Research Vials

PEPTIDE RESEARCH TRENDS TO WATCH IN 2026

The five biggest trends shaping peptide research in 2026 — from GLP-1 agonist evolution to mitochondrial peptides, AI-driven discovery, and the post-Peptide Sciences landscape.

Research Vials
◤ Article · Peptide-anchored

AOD-9604 VS SEMAGLUTIDE: METABOLIC RESEARCH HEAD-TO-HEAD COMPARISON PUBLISHED...

AOD-9604 (a fragment of HGH studied for fat metabolism) and Semaglutide (a GLP-1 receptor agonist) target metabolic function through very different mechanisms. This comparison maps what the research shows for each — and where their effects overlap or diverge.

Research Vials
◤ Article · Peptide-anchored

WOLVERINE BLEND: BPC-157 + TB-500 COMBINATION RESEARCH — WHAT THE STUDIES ACTUALLY SHOW...

BPC-157 (a peptide studied for gut and tendon repair) and TB-500 (Thymosin Beta-4, studied for cell migration and recovery) are among the most co-researched peptides in the field. This piece reviews the published evidence for their combined use and where the data is still thin.

Research Vials
▶ Video

ORFORGLIPRON VS RETATRUTIDE?

Choosing between Orforglipron and Retatrutide can be challenging, especially as new research continues to emerge on their effectiveness for weight loss, metabolic health, and type 2 diabetes. Understanding the differences between these ther

Regan Archibald
▶ Video

THE 7 THINGS THAT ARE SHRINKING YOUR BRAIN

How to Reverse Cognitive Decline, Grow Your Hippocampus, and Protect Your Brain from Alzheimer's Disease with Nutrition, Exercise, Sleep, and Stress Reduction Your brain is physically shrinking right now, and most people have no idea it's

Dave Asprey

More Headlines